1,799
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Knock out hepatic Krüppel-like factor 16 (KLF16) improve myocardial damage and promoted myocardial protection of myocardial ischemia-reperfusion via anti-oxidative and anti-inflammation effects by TFAM/PPARβ signal passage

, ORCID Icon, , , , , , , & show all
Pages 10219-10231 | Received 28 Jun 2021, Accepted 14 Sep 2021, Published online: 25 Nov 2021

References

  • Boag SE, Andreano E, Spyridopoulos I, Andreano E, Spyridopoulos I. lymphocyte communication in myocardial ischemia/reperfusion injury. Antioxid Redox Signal. 2017;26(12):660–675.
  • Chen L, Zhang D, Yu L, Yu L, Dong H: Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury. Bioengineered. 2019;10(1):121–132.
  • !!! INVALID CITATION !!!
  • Koh JH, Johnson ML, Dasari S, et al. TFAM enhances fat oxidation and attenuates high-fat diet-induced insulin resistance in skeletal muscle. Diabetes. 2019;68:1552–1564.
  • Papatheodorou I, Galatou E, Panagiotidis GD, et al. Cardioprotective effects of PPARβ/δ activation against ischemia/reperfusion injury in rat heart are associated with ALDH2 upregulation, amelioration of oxidative stress and preservation of mitochondrial energy production. Int J Mol Sci. 2021Jun 15;22(12):6399.
  • Liu WY, Sun HH, Sun PF. MicroRNA-378 attenuates myocardial fibrosis by inhibiting MAPK/ERK pathway. Eur Rev Med Pharmacol Sci. 2019;23:4398–4405.
  • Huang DD, Huang HF, Yang Q, et al. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice. Eur Rev Med Pharmacol Sci. 2018;22:4648–4656.
  • Mao S, Tian S, Luo X, et al. Cao Z and Li J: overexpression of PLK1 relieved the myocardial ischemia-reperfusion injury of rats through inducing the mitophagy and regulating the p-AMPK/FUNDC1 axis. Bioengineered. 2021;12(1):2676–2687.
  • Hao L, Zhong W, Dong H, et al. ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis. Gut. 2020Oct;70(10):1933-1945.
  • Leal VO. PPARβ/δ: benefits in coronary artery disease and beyond. Arq Bras Cardiol. 2019;113:1128.